Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naı̈ve patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection

This publication has 29 references indexed in Scilit:

• Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS
  Clinical Infectious Diseases, 2003
• Effect of Highly Active Antiretroviral Therapy (HAART) and Hepatitis C Co-Infection on Hyperlipidemia in HIV-Infected Patients: A Retrospective Longitudinal Study
  HIV Research & Clinical Practice, 2002
• NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
  Hepatology, 2002
• Evolution of Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus in Patients Treated with Highly Active Antiretroviral Therapy
  Clinical Infectious Diseases, 2001
• Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV–Hepatitis C Virus–Coinfected Patients Undergoing Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Increased Risk of Type 2 Diabetes in Noncirrhotic Patients With Chronic Hepatitis C Virus Infection
  Mayo Clinic Proceedings, 2000
• Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection
  Hepatology, 1999
• Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
  Hepatology, 1999
• Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
  Journal of Clinical Endocrinology & Metabolism, 1992
• Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease.
  Journal of Clinical Pathology, 1978